Stephens Consulting’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-500
| Closed | -$5.74K | – | 507 |
|
|
2023
Q3 | $5.74K | Hold |
500
| – | – | ﹤0.01% | 364 |
|
|
2023
Q2 | $12.7K | Hold |
500
| – | – | 0.01% | 285 |
|
|
2023
Q1 | $16.1K | Hold |
500
| – | – | 0.01% | 267 |
|
|
2022
Q4 | $9.23K | Hold |
500
| – | – | 0.01% | 310 |
|
|
2022
Q3 | $13.5K | Hold |
500
| – | – | 0.01% | 291 |
|
|
2022
Q2 | $6.91K | Hold |
500
| – | – | 0.01% | 372 |
|
|
2022
Q1 | $9.75K | Hold |
500
| – | – | 0.01% | 353 |
|
|
2021
Q4 | $8.16K | Buy |
+500
| New | +$8.16K | 0.01% | 413 |
|